Clinical Trial Update: Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a regimen of fluorouracil, cisplatin, leucovorin calcium, and cetuximab for adenocarcinoma of the stomach or gastroesophageal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Gastroesophageal Junction
• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• FLUOROURACIL (Fluorouracil)
• Leucovorin calcium (calcium folinate)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Adenocarcinoma of the Gastroesophageal Junction, Gastric Cancer | Phase 2 | Status: COMPLETED